Systemic therapy clinical trials

Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma

This study looks at a new combination treatment, Atezolizumab-Bevacizumab, for liver transplant patients in the UK with advanced liver cancer that has come back. It aims to see if this treatment is safe and effective when used with special medicines to prevent organ rejection.